July 1st 2025
Vaccine candidate demonstrates 26.6% higher relative efficacy in adults 50 and older, with strong protection across flu strains.
Cloudbreak Antiviral Conjugate Demonstrates Potent In Vitro Activity
April 16th 2019Cidara Therapeutics has developed CB-012, a stable conjugate of a highly potent antiviral agent linked to human IgG1 Fc, and investigators are evaluating the asset for the treatment and prevention of seasonal and pandemic influenza A and B infections.
Read More
Flu Shot, Nasal Spray Recommended Equally for Kids for 2019-2020 Season
April 2nd 2019The American Academy of Pediatrics is giving its recommendation to the nasal spray form of the influenza vaccine for the 2019-2020 flu season, meaning parents will have 2 choices when getting their children vaccinated this fall.
Read More